189 related articles for article (PubMed ID: 37640858)
1. Cell-free DNA methylome analysis for early preeclampsia prediction.
De Borre M; Che H; Yu Q; Lannoo L; De Ridder K; Vancoillie L; Dreesen P; Van Den Ackerveken M; Aerden M; Galle E; Breckpot J; Van Keirsbilck J; Gyselaers W; Devriendt K; Vermeesch JR; Van Calsteren K; Thienpont B
Nat Med; 2023 Sep; 29(9):2206-2215. PubMed ID: 37640858
[TBL] [Abstract][Full Text] [Related]
2. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E
Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877
[TBL] [Abstract][Full Text] [Related]
4. Cell-free DNA methylation-based preeclampsia prediction: A journey to improve maternal health.
Aerden M; De Borre M; Thienpont B
Prenat Diagn; 2024 Apr; 44(4):418-421. PubMed ID: 38047711
[TBL] [Abstract][Full Text] [Related]
5. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome.
Muñoz-Hernández R; Medrano-Campillo P; Miranda ML; Macher HC; Praena-Fernández JM; Vallejo-Vaz AJ; Dominguez-Simeon MJ; Moreno-Luna R; Stiefel P
Am J Hypertens; 2017 Jul; 30(7):673-682. PubMed ID: 28338787
[TBL] [Abstract][Full Text] [Related]
6. Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.
Murtoniemi K; Villa PM; Matomäki J; Keikkala E; Vuorela P; Hämäläinen E; Kajantie E; Pesonen AK; Räikkönen K; Taipale P; Stenman UH; Laivuori H
BMC Pregnancy Childbirth; 2018 Jul; 18(1):279. PubMed ID: 29970026
[TBL] [Abstract][Full Text] [Related]
7. Biological Insights from Cell-Free DNA Methylome Analysis in Preeclampsia.
Yu SCY; Lo YMD
Clin Chem; 2024 Jun; 70(6):789-791. PubMed ID: 38451049
[No Abstract] [Full Text] [Related]
8. Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia.
Rolnik DL; da Silva Costa F; Lee TJ; Schmid M; McLennan AC
Ultrasound Obstet Gynecol; 2018 Dec; 52(6):722-727. PubMed ID: 29318732
[TBL] [Abstract][Full Text] [Related]
9. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
[TBL] [Abstract][Full Text] [Related]
10. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
[TBL] [Abstract][Full Text] [Related]
11. Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia.
Jung YW; Shim JI; Shim SH; Shin YJ; Shim SH; Chang SW; Cha DH
Medicine (Baltimore); 2019 Jan; 98(3):e13971. PubMed ID: 30653101
[TBL] [Abstract][Full Text] [Related]
12. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
[TBL] [Abstract][Full Text] [Related]
13. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
[TBL] [Abstract][Full Text] [Related]
14. First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort.
Oliveira N; Magder LS; Blitzer MG; Baschat AA
Ultrasound Obstet Gynecol; 2014 Sep; 44(3):279-85. PubMed ID: 24913190
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary study of human serum albumin level in early warning onset of preeclampsia].
Shi JM; Yang Z; Li FQ; Wang GJ
Zhonghua Fu Chan Ke Za Zhi; 2020 Jan; 55(1):29-35. PubMed ID: 32074770
[No Abstract] [Full Text] [Related]
16. Revised competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history.
Benkő Z; Chaveeva P; de Paco Matallana C; Zingler E; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Nov; 54(5):617-624. PubMed ID: 31364214
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia.
Lee SM; Kang Y; Lee EM; Jung YM; Hong S; Park SJ; Park CW; Norwitz ER; Lee DY; Park JS
Sci Rep; 2020 Sep; 10(1):16142. PubMed ID: 32999354
[TBL] [Abstract][Full Text] [Related]
18. Cell-Free Foetal DNA as a Useful Marker for Preeclampsia Prediction.
Karapetian АО; Baev ОR; Sadekova АА; Krasnyi АМ; Sukhikh GT
Reprod Sci; 2021 May; 28(5):1563-1569. PubMed ID: 33475978
[TBL] [Abstract][Full Text] [Related]
19. First-Trimester Placental Growth Factor for the Prediction of Preeclampsia in Nulliparous Women: The Great Obstetrical Syndromes Cohort Study.
Boutin A; Demers S; Gasse C; Giguère Y; Tétu A; Laforest G; Bujold E
Fetal Diagn Ther; 2019; 45(2):69-75. PubMed ID: 30304731
[TBL] [Abstract][Full Text] [Related]
20. Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia.
Mach P; Nolte-Boenigk L; Droste L; Fox L; Frank M; Schmidt B; Herse F; Verlohren S; Wicherek L; Iannaccone A; Birdir C; Andrikos D; Kimmig R; Gellhaus A; Köninger A
Am J Reprod Immunol; 2018 Sep; 80(3):e12988. PubMed ID: 29797540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
